Impact Accounts Payable vs Cash Analysis
IBO Stock | USD 1.80 0.05 2.70% |
Impact BioMedical, financial indicator trend analysis is infinitely more than just investigating Impact BioMedical, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Impact BioMedical, is a good investment. Please check the relationship between Impact BioMedical, Accounts Payable and its Cash accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.
Accounts Payable vs Cash
Accounts Payable vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Impact BioMedical, Accounts Payable account and Cash. At this time, the significance of the direction appears to have pay attention.
The correlation between Impact BioMedical,'s Accounts Payable and Cash is -0.96. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash in the same time period over historical financial statements of Impact BioMedical,, assuming nothing else is changed. The correlation between historical values of Impact BioMedical,'s Accounts Payable and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Impact BioMedical, are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Accounts Payable i.e., Impact BioMedical,'s Accounts Payable and Cash go up and down completely randomly.
Correlation Coefficient | -0.96 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Impact BioMedical, obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Impact BioMedical, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Cash
Cash refers to the most liquid asset of Impact BioMedical,, which is listed under current asset account on Impact BioMedical, balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Impact BioMedical, customers. The amounts must be unrestricted with restricted cash listed in a different Impact BioMedical, account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Impact BioMedical,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Impact BioMedical, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.Tax Provision is expected to grow at the current pace this year, while Selling General Administrative is likely to drop about 1.1 M.
2020 | 2023 | 2024 | 2025 (projected) | Total Operating Expenses | 3.5M | 4.0M | 4.6M | 3.2M | Research Development | 1.2M | 1.1M | 1.3M | 1.1M |
Impact BioMedical, fundamental ratios Correlations
Click cells to compare fundamentals
Impact BioMedical, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Impact BioMedical,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Impact BioMedical, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will appreciate offsetting losses from the drop in the long position's value.Moving against Impact Stock
0.57 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.56 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.51 | LLY | Eli Lilly | PairCorr |
The ability to find closely correlated positions to Impact BioMedical, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Impact BioMedical, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Impact BioMedical, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Impact BioMedical, to buy it.
The correlation of Impact BioMedical, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Impact BioMedical, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Impact BioMedical, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Impact BioMedical, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.